# Daily, Encapsulated, Green Tea Extract to Mitigate Neuropathic Pain in Patients With Established Cancer-Associated Neuropathic Pain

> **NCT07682324** · PHASE1 · NOT_YET_RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 20 (estimated)

## Conditions studied

- Neuropathic Pain
- Cancer Treatment

## Interventions

- **DIETARY_SUPPLEMENT:** Green Tea Leaf Extract Decaffeinated
- **OTHER:** Placebo Control

## Key facts

- **NCT ID:** NCT07682324
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-30
- **Primary completion:** 2029-01-08
- **Final completion:** 2029-03-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07682324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07682324, "Daily, Encapsulated, Green Tea Extract to Mitigate Neuropathic Pain in Patients With Established Cancer-Associated Neuropathic Pain". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07682324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*